Dermatomyositis‐specific autoantibodies such as anti‐TIF‐1γ have been shown to tightly correlate with organ involvement and malignancy in cancer‐associated myositis (2, 4, 5, 10). The gene discussed is TRIM33; the disease is dermatomyositis.